Discover how rhamnose-modified antibodies are transforming cancer immunotherapy through in situ self-assembly techniques for enhanced precision and effectiveness.
Discover how FF-10101, a novel CSF1R inhibitor with unique covalent binding, reprograms tumor-associated macrophages to create an anti-tumor immune environment and enhances cancer immunotherapy.
An exploration of recent M&A activity, using biological metaphors to explain the strategies behind corporate mergers and acquisitions, featuring case studies like Pfizer-Seagen.
Exploring the promising role of non-platinum metal complexes like ruthenium and gold in cancer therapy, their mechanisms, and clinical progress.
Discover how gecko feet inspired revolutionary biomimetic adhesives that are strong, reusable, and residue-free. Explore the science behind this breakthrough technology.
How scientists are unlocking the secrets of bioactive compounds from plants and fungi to fight disease through isolation, characterization and biological testing.
Discover how prenylation, the process of adding a prenyl group to aromatic drugs, is enhancing drug targeting and bioavailability, revolutionizing modern medicine.
Explore how QSAR modeling and artificial neural networks are accelerating the development of PDE10A inhibitors for treating neurological disorders, cancer, and heart conditions.
Exploring phospa-trastuzumab, a bifunctional methylenephosphonate-based chelator that's advancing cancer theranostics with radiometals 89Zr, 111In, and 177Lu.
How scientists are using revolutionary 'click chemistry' to build precision gene therapies that hunt down prostate cancer cells.